Find the latest clinical trials by condition, location & phase
Browse and search for drug information and related clinical trials
Explore a comprehensive list of organizations, including their profiles and details.
Latest updates on clinical trials, pharmaceuticals, and healthcare companies
Stay informed with timely notifications on clinical trials and research advancements.
No overview information available.
No background information available.
No indication information available.
No associated conditions information available.
Zymeworks is set to advance ZW171 and ZW191 in Phase 1 trials for solid tumors, part of their '5 by 5' R&D program.
Zymeworks has dosed the first patient in a Phase 1 clinical trial evaluating ZW171 for advanced ovarian cancer, NSCLC, and other mesothelin-expressing cancers.
Zymeworks Inc. will release its third-quarter 2024 financial results after market close on October 31, 2024.